本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trevi Therapeutics Inc.

12.93
-0.0050-0.04%
成交量:9.24万
成交额:119.71万
市值:18.35亿
市盈率:-36.74
高:13.19
开:12.86
低:12.81
收:12.93
52周最高:20.22
52周最低:9.28
股本:1.42亿
流通股本:1.18亿
量比:0.28
换手率:0.08%
股息:- -
股息率:- -
每股收益(TTM):-0.3518
每股收益(LYR):-0.3173
净资产收益率:-19.66%
总资产收益率:-13.82%
市净率:5.71
市盈率(LYR):-40.73

数据加载中...

2023/04/11

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/16

重要事件披露

8-K - Current report
2023/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/23

重要事件披露

8-K - Current report
2022/09/19

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/29

重要事件披露

8-K - Current report
2022/06/23

重要事件披露

8-K - Current report